Work

Final clinical, pharmacokinetic and pharmacodynamic results of the phase I study of the novel poly(ADP-ribose)polymerase (PARP) inhibitor, AG014699, in combination with temozolomide

Year: 2005

Type: conference-paper

Source: Newcastle University ePrints (Newcastle Univesity)

DOI: 10.25405/ncl.34698168

Authors: Elizabeth Plummer, M Middleton, R Wilson, J Evans, C Jones, A Olson, A Boddy, Nicola Curtin, R Kaufman, A Harris, P Johnston, David Newell, L Robson, R Dewji, Alan Calvert

Institution: Newcastle University

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W186885463

FWCI: 16.37

Cites:

Cited by: 7

Related to: 10